A CNBC reporter since 1990, Bob Pisani has reported on Wall Street and the stock market from the floor of the New York Stock Exchange for more than a decade. Pisani covered the real estate market for CNBC from 1990-1995, then moved on to cover corporate management issues before moving to the New York Stock Exchange in 1997.
He was nominated twice for a "CableACE Award"—in 1993 and 1995.
In 2013, he won Third Place in the National Headliner Awards in the Business and Consumer Reporting category for his documentary on the diamond business, "The Diamond Rush."
In 2014, Bob was honored with a Recognition Award from the Market Technicians Association for "steadfast efforts to integrate technical analysis into financial decision making, journalism and reporting."
Prior to joining CNBC, Pisani co-authored "Investing in Land: How to Be a Successful Developer." He and his father taught a course in real estate development at the Wharton School of Business at the University of Pennsylvania from 1987-1992. Pisani learned the real estate business from his father, Ralph Pisani, a retired real estate developer.
Follow Bob Pisani on Twitter
Citi is providing the main upside impetus, but relief that big industrials like Caterpillar and Honeywell did not repeat GE's concern that last two weeks of March fell apart is also a big help; the dollar has rallied. Today is an options expiration day.
Futures popped right after the close as Google reported strong numbers; up 10 percent. Major indices stable today, despite mixed earnings report. IBM, good, Marriott, ok on strong international sales, but Conway, Nokia and Pfizer were notable disappointments.
The markets might be off to a painful start this year, but new ETFs keep coming out. The latest out just this week is a whole suite of ETFs that track several key international exchanges.
IBM up about 3 percent after the bell to a new multi-year high on earnings that beat expectations. The surge is not just about the beat -- but how they did it: hardware was flat, as expected (there were fears it would be weaker), software was strong, and services (more than half of revenues) were very strong
Bill Ackman also tells CNBC that Allergan's poison-pill defense doesn't make his takeover bid more difficult.
The bull market is seeing the equivalent of its first gray hairs and the proof is in Tuesday's blast of merger activity.
Greenlight Capital supports the subject of the book 'Flash Boys' and thinks investors should consider routing orders there.